"Teva Pharmaceuticals has finally launched its generic version of Mylan’s EpiPen. The Petah, Tikvah, Israel-based company’s emergency allergy shot will be priced at $300 – the same as Mylan’s generic. Teva received approval for its version of EpiPen in August.
The generic will be available in limited supply and the company will launch a lower-dose – the EpiPen Jr. sometime next year, the company said.
“We’re pleased to provide access to Epinephrine Injection (Auto-Injector) for patients who may experience life-threatening allergic emergencies and we’re fully dedicated toward ensuring additional supply in 2019,” Brendan O’Grady, EVP"
Sourced through Scoop.it from: www.mddionline.com